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INTRODUCTION
In the last three decades low back pain was globally the 
highest-ranking cause of disability [1]. Most patients with 
acute low back pain recover within six weeks. Approxi-
mately 5%-10% of patients with low back pain experience 
persistent symptoms lasting more than the expected 
recovery time [2]. Lumbar radiculopathies are the most 
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Background: This study investigated whether current smoking and a higher nico-
tine dependency were associated with chronic low back pain (LBP), lumbar related 
leg pain (sciatica) and/or radicular neuropathic pain. 
Methods: A cross-sectional study was conducted on 150 patients (mean age, 60.1 
± 13.1 yr). Demographic data, the International Association for the Study of Pain 
(IASP) neuropathic pain grade, STarT Back tool, and the Fagerström test were com-
pleted. A control group (n = 50) was recruited.
Results: There was a significant difference between current smokers and non-
smokers in the chronic LBP group in the mean pain score (P = 0.025), total STarT 
Back score (P = 0.015), worst pain location (P = 0.020), most distal pain radiation (P 
= 0.042), and in the IASP neuropathic pain grade (P = 0.026). There was a signifi-
cant difference in the mean Fagerström score between the four IASP neuropathic 
pain grades (P = 0.005). Current smoking yielded an odds ratio (OR) of 3.071 (P = 
0.011) for developing chronic LBP and sciatica, and an OR of 4.028 (P = 0.002) for 
obtaining an IASP “definite/probable” neuropathic pain grade, for both cohorts. The 
likelihood for chronic LBP and sciatica increased by 40.9% (P = 0.007), while the 
likelihood for an IASP neuropathic grade of “definite/probable” increased by 50.8% 
(P = 0.002), for both cohorts, for every one unit increase in the Fagerström score.
Conclusions: A current smoking status and higher nicotine dependence increase 
the odds for chronic LBP, sciatica and radicular neuropathic pain. 
Key Words: Chronic Pain; Cross-Sectional Studies; Low Back Pain; Neuralgia; Nico-
tine; Non-Smokers; Radiculopathy; Smoking; Tobacco Use Disorder.
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frequently encountered neuropathic pain condition [3], 
the latter being defined as “pain arising as a direct conse-
quence of a lesion or disease affecting the somatosensory 
system” by the International Association for the Study of 
Pain (IASP) [4]. Lumbar radiculopathies are considered to 
be mainly of a neuropathic nature [5], hence their higher 
disability and chronification, compared to axial low back 
pain, which is thought to arise primarily due to nocicep-
tive pain [6]. This is clinically evident by the refractoriness 
of neuropathic pain to treatment, including strong analge-
sics [7]. 
Multiple organ systems are adversely affected by ciga-
rette smoking, including an increased risk for low back 
pain [8,9], sciatica [10] and development of various periph-
eral neuropathies [11-14]. The latter are a prerequisite for 
the development of neuropathic pain [3]. Smokers tend 
to report higher pain intensity, require more analgesics, 
and their pain impacts more negatively on their lives, 
compared to non-smokers [15]. Çelik et al. [16] evaluated 
nicotine dependence using the Fagerström Test for Nico-
tine Dependence and neuropathic pain using the Douleur 
Neuropathique 4 (DN4) questionnaire. They found a sig-
nificant correlation between the number of packets of cig-
arettes smoked per year and a positive DN4 score. Howev-
er, this study did not report the pathoanatomical etiology 
leading to neuropathic pain; hence the analysis of specific 
patient subgroups, which could be more susceptible to the 
negative impact of smoking on neuropathic pain could not 
be carried out. 
The updated IASP neuropathic pain grading system 
states that the use of neuropathic pain questionnaires, like 
the DN4, can lead only to a “possible” neuropathic pain 
grade [17], but the sensory examination of the DN4 can po-
tentially increase a “possible” neuropathic pain grade to a 
“probable” one. However, the DN4 includes only two sen-
sory modalities, while IASP grading system bedside sen-
sory testing advocates testing for at least five sensory mo-
dalities. The psychometric properties of the DN4 vary with 
the pain etiology, which influenced the validity of results, 
for example in post lumbar surgery, the DN4 obtained a 
sensitivity of 62% and a specificity of 44% [18] while in low 
back pain it obtained a sensitivity of 80% and a specific-
ity of 92% [19]. In their study, Çelik et al. [16] did not assess 
for any psychological factors which have been found have 
a crucial role in both neuropathic pain perpetuation and 
smoking habits [15]. Furthermore, this study did not men-
tion if ex-smokers were included and adjusted for in their 
results. 
This paper aims to improve on Çelik et al. [16]. It is a 
cross-sectional study to investigate the association be-
tween patients with chronic low back pain with nicotine 
addiction and daily cigarette consumption. The patient 
group includes a subset of patients suffering from radicu-
lar neuropathic pain. The study’s objectives were to evalu-
ate the following null hypotheses:
1. A higher Fagerström score did not increase the risk for 
chronic low back pain, sciatica, or chronic radicular 
neuropathic pain.
2. Current smokers do not have an increased risk for 
chronic low back pain, sciatica, or chronic radicular 
neuropathic pain compared to lifetime non-smokers.
3. Current smokers do not have higher pain intensity 
and STarT Back scores compared to lifetime non-
smokers. 
4. Male smokers do not have an increased incidence of 
chronic low back pain, lumbar related leg pain (sciat-
ica), or chronic radicular neuropathic pain compared 
to female smokers.
MATERIALS AND METHODS
1. Study design and setting
Ethical approval for this study was obtained from the 
research committee at a local rehabilitation hospital in 
Malta, Europe (04/03/2019). During their first session 
patients referred for chronic low back pain, sciatica, or 
chronic radicular neuropathic pain, were approached by 
a third party, independent of the study. Written informed 
consent was obtained from all study participants. All 
procedures performed in studies involving human par-
ticipants were in accordance with the ethical standards 
of the institutional research committee and with the 1964 
Helsinki declaration and its later amendments or compa-
rable ethical standards. The study was conducted between 
March and November 2019 in a Musculoskeletal Physio-
therapy Outpatient Clinic. The term chronic low back pain 
referred to pain in the region between the lower thoracic 
margin and the horizontal gluteal folds extending beyond 
three months [20]. Pain distal to the gluteal fold was con-
sidered as pain in the lower limb. Radicular neuropathic 
pain referred to neuropathic pain according to the IASP in 
a radicular pattern [4]. Lumbar related leg pain (sciatica) 
referred to any pain radiation into the leg, be it of nocicep-
tive or neuropathic origins. 
This study was conducted at the local rehabilitation 
hospital’s Musculoskeletal Physiotherapy Outpatients De-
partment. The final sample size, hereunder referred to as 
the “chronic pain group” was determined by the number 
of referrals recruited by the clinic and examined by the 
principal investigator (ES) during the eight-month data 
collection period (March to November 2019). A control 
group free from chronic low back pain and/or sciatica 
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for the past year was recruited (n = 50, Fig. 1). The control 
group was adequately age- and sex-matched to the chronic 
pain group. The patients included in this study form part 
of an ongoing observational study evaluating the manage-
ment and outcome of patients with chronic spinal pain 
attending the Musculoskeletal Physiotherapy Outpatients 
Department at a local rehabilitation hospital in Malta. The 
Strengthening the Reporting of Observational studies in 
Epidemiology (STROBE) statement was used throughout 
this paper [21]. 
2. Participants 
Subjects of both sexes were included in the chronic pain 
group if they fulfilled all of the following criteria: 1) above 
18 years of age; 2) referred to the Musculoskeletal Physio-
therapy Outpatient’s facilities for chronic low back and/or 
sciatica; 3) with pain duration of ≥ 3 months; 4) who were 
either lifetime non-smokers or current smokers. 
Subjects were excluded from taking part in this study 
if they were unable to complete all the questionnaires, 
suffered from psychosis or severe depression, cognitive 
impairment or intellectual disability, substance abuse 
or severe alcoholism, known diabetic neuropathy or had 
been diagnosed with length-dependent polyneuropa-
thy, had pain of unknown origin, visceral pain, complex 
regional pain syndrome, headaches, had severe muscu-
loskeletal pain, other than chronic low back pain and/or 
sciatica, and significant comorbidities. Subjects who lived 
with a partner/relative who smoked were also excluded 
from this study due to passive smoking. Ex-smokers were 
excluded as the harmful effects of smoking can last for up 
to 30 years. Thus, smoking cessation can reduce but not 
eliminate the risk of the onset of low back pain [10]. There-
fore, it was decided to remove participants who were for-
mer smokers. The control group needed to reach the same 
criteria, except they must not have complained of chronic 
low back pain and sciatica over the past year. 
3. Patient-reported outcome measures 
1) Demographics 
Demographic data on sex, age, occupation (housewife/
man, light work or manual work), and pain chronicity 
were recorded for the chronic pain group. 
2) Pain assessment 
Three separate numerical rating scales (NRS) for lowest, 
mean, and highest pain intensity were used. Each of the 
three individual NRS had the anchors “no pain” and “worst 
imaginable pain (0-10).” The expected mean age from 
clinical experience was expected between 50 and 60 years 
of age therefore the NRS was preferred over the visual 
analogue scale, since the latter is associated with a higher 
frequency of incomplete scores with an increase in the 
participants’ age [22]. The worst pain location was classi-
fied as either in the lower limb or in the low back. The most 
distal pain radiation was categorized into five sections: the 
low back, thigh and/or knee, upper calf, lower calf and/or 
ankle, and in the foot [23]. 
The drug history was self-reported, as it is not listed in 
the referral form. Analgesic drugs were categorized into 
the five main classes: opioids, antidepressants, gabapen-
tinoids, non-steroidal anti-inflammatory drugs, and ac-
etaminophen. From this data, the current number of oral 
analgesic drug classes being used, irrespective of dosage 
All subjects, including those with chronic pain and pain free
Confirmed eligibility and were asked for a written informed consent
Subjects with chronic LBP and/or
sciatic pain (n = 184)
Completed all the questionnaires and
the physical examination
Chronic pain group (n = 150) Control group (n = 50)
Pain free subjects
(control group) (n = 59)
Excluded (n = 8)
Former smokers (n = 4)
Did not understand or complete all the
Fagerstrom tool (n = 1)
Lived with a partner who smoked (n = 3)
Completed all the questionnaires and
the physical examination
Excluded (n = 34)
Consent not given (n = 5)
Former smokers (n = 9)
Did not understand or complete all the
questionnaires (n = 5)
Lived with a partner who smoked (n = 7)
Lower limb pain not of spinal origin (n = 4)
Pain < 3 months (n = 4)
Fig. 1. Flow diagram of the participants in 
the study. LBP: low back pain.
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and frequency, was recorded. Patients using combination 
analgesic formulations were grouped together.
The IASP neuropathic pain grading system [17] was used 
to systematically grade the probability of the presence of 
neuropathic pain in the chronic pain group. With regards 
to the pain being in a neuroanatomically plausible distri-
bution, the various dermatome charts were consulted to 
try to allocate the painful area to a specific spinal level. 
In subjects who could not be easily assigned to a specific 
spinal level via the dermatome charts (e.g., pain radiated 
to either aspect of the calf only), this did not hinder these 
participants’ progression in the IASP grading system, 
considering that dermatomes are malleable physiological 
constructs and can vary substantially [24].
The first author (ES) completed a bedside-derived quan-
titative sensory examination in the most painful area 
identified by the participants [17]. The examination pro-
cedure was adopted from the study by Hasvik et al. [23]. 
The examination included the response to static pressure, 
dynamic light tactile touch, pinprick, vibration, windup, 
warm and cold, and sensory threshold to punctate tactile 
stimulation. Initially, a demonstration was performed on 
the patients’ arm, followed by testing in the most painful 
area. The latter was compared to a homologous contralat-
eral reference site. Two repetitions of each test procedure 
were done.
Dynamic light tactile touch was assessed with two 
strokes over 2-3 cm using a SENSELabTM Brush-05 (Somed-
ic SenseLab AB, Sösdala, Sweden). Static pressure was as-
sessed using the blunt side of the brush with just enough 
pressure to indent the skin. Pinprick was assessed using 
a 5.1 g Semmes-Weinstein type monofilament (Baseline® 
Tactile MonofilamentsTM; Fabrication Enterprises Inc., 
White Plains, NY, USA). Wind up (temporal summation) 
was assessed by using the same 5.1 g Semmes-Weinstein 
type monofilament and applied at 2 Hz for 30 seconds. 
Cold and warm temperatures were assessed by using 
two test tubes, each one filled with water at 25°C or 40°C, 
which was rolled slowly with minimal pressure. Semmes-
Weinstein type monofilaments ranging from 0.07 g to 
300.0 g (Baseline® Tactile MonofilamentsTM) were used to 
test for the sensory detection threshold, where the value 
corresponding to the monofilament force was used. The 
lowest detected monofilament strength was recorded. The 
vibration detection threshold was evaluated using a Rydel-
Seiffer 128 Hz graduated (8/8 scale) tuning fork (Baseline® 
Rydel-Seiffer; Fabrication Enterprises Inc.). The patient’s 
instant report when the vibration sensation disappeared 
marked the lowest vibration threshold, with the value cor-
responding to the tuning fork 8/8 scale. Vibration testing 
was first conducted on the painful side and then on a bony 
prominence if the two did not coincide. The choice of the 
bony prominence was based on the dermatome supplied 
by the nerve root suspected to be causing the pain and the 
sensory changes (e.g., the medial aspect of the hallux in 
the case where L5 radiculopathy is suspected). The mean 
value of the two repetitions was recorded [23]. 
The patient’s subjective score was used in case of the 
loss to static or dynamic light tactile pressure and touch, 
pinprick, vibration, warm and cold. Scoring was done as 
no sensation, decreased, normal, or increased sensation. 
A reduced or complete loss of sensation was classified as a 
negative sensory sign. In cases where the pain was elicited 
by the test modality, a NRS (0-10) was administered to the 
patient. During the examination for wind up, the presence 
of pain escalation during the testing procedure was con-
sidered at par to hypoesthesia to the other sensory modali-
ties. In case of an inconsistent result between the two test 
repetitions, the result for the specific testing modality was 
scored as a normal response. In the absence of negative 
sensory signs in the most painful area, the sensory exami-
nation was repeated in another painful area within the 
same neuroanatomically plausible distribution (usually 
within the lower limb, especially in cases where the worst 
pain location was the low back). 
The patient interview and clinical assessment were used 
to classify patients according to the IASP neuropathic 
pain special interest group grading system into “unlikely,” 
“possible,” “probable,” and “definite” neuropathic pain [17] 
(Fig. 2). A grade of “definite” neuropathic pain was based 
on an magnetic resonance imaging (MRI) scan showing 
a disc lesion or a stenotic lumbar level (including canal, 
foraminal, and lateral recess stenosis) corresponding to 
the clinical signs and symptoms. In subjects graded with 
“possible” neuropathic pain, and where the sensory signs 
were difficult to demonstrate but the MRI confirmed the 
nature of the lesion, the level of “probable” neuropathic 
pain was used, as stated in the legend of Fig. 2 of Finnerup 
et al. [17]. In those patients who were not graded as having 
“probable” neuropathic pain by this approach, the meth-
odology adopted by Hasvik et al. [23] was used to classify 
patients with chronic low back pain according to the IASP 
neuropathic pain grading system [17]. Henceforth, the pa-
tient data were manually reviewed by three of the authors 
(ES, VM, SLM) for sensory abnormalities outside of the 
most painful area. 
Owing to the reduced probability that neuropathic pain 
arises from positive sensory signs [17], distinct signs from 
other modalities and direct evidence for radiculopathies 
from strictly neuroanatomically plausible distributions, 
e.g., corresponding tendon reflex or myotomal muscle 
weakness, were necessary to grade the patient with “prob-
able” NP (Fig. 2). This approach is justified, since spinal 
nerves are mixed sensory and motor nerves, and the pres-
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ence of negative motor signs portray a neural conduction 
block, which is the prerequisite for neuropathic pain [25]. 
3) Smoking
The Fagerström Test for Nicotine Dependence quantifies 
the nicotine addiction risk [26]. This test consists of six 
questions with a possible total score ranging from 0-10. 
A score of 8-10 indicates very high dependence, 6-7 high 
dependency, 5 medium dependence, 3-4 low dependence, 
0-2 signifies minimal nicotine dependence. Item number 
4 of the Fagerström Test measures the number of cigarettes 
smoked daily grouped into four categories. A higher ciga-
rette consumption on this variable contributes to a higher 
total score on the questionnaire. The number of cigarettes 
smoked daily (item number 4) and the overall Fagerström 
score, were included separately in the analysis. 
4) Outcome predictor 
The STarT Back tool measures an overview of treatment-
modifiable domains, including disability, pain radiation, 
and psychological factors, all of which are amenable to 
treatment [27]. The total score ranges from 0 to 9, and it 
is scored by adding up the positive responses. The STarT 
Back distress subscale score ranges from 0 to 5, and is 
composed of a question each assessing fear, catastroph-
izing, depression, anxiety, and bothersomeness. This 
subscale can replace the use of multiple unidimensional 
psychological tools as a primary screening tool for psycho-
logical issues. The individual items in the distress subscale 
were related to full length unidimensional psychological 
questionnaires in a secondary care physiotherapy outpa-
tient department [28]. The total STarT Back score, but even 
more the distress subscore, predicted pain severity [29]. 
A higher psychosocial score was related to a higher risk of 
pain. The STarT Back score had a correlation of 0.4 with 
disability and fear of movement [30]. The overall STarT 
Back scores (β = 0.22) and STarT Back psychosocial scores 
(β = 0.25) predicted disability at 6 months [31]. The distress 
subscore and the total STarT Back score were included as 
separate variables in the analysis.
To minimize bias by the principal investigator, the STarT 
Back tool and the Fagerström Test were administered at 
the end of the clinical assessment. To obtain single blind-
ing, the participants were briefed about the aims of the 
study but not about the content of the data collection. The 
participants were instructed to fill up the questionnaires 
independently on paper. If they encountered any difficul-
ties, the assessor was able to help them. 
5) Control group
All participants within the control group had to self-report 
the above measures except those related to pain.
4. Statistical methods 
All questionnaires were entered into the SPSS ver. 25.0 sta-
tistics package (IBM Co., Armonk, NY, USA), with which 
Fig. 2. Flow diagram of the chronic pain subjects’ International Association for the Study of Pain neuropathic pain (NP) grading. MRI: magnetic resonance 
imaging.
If only positive sensory changes
are present, evidence from tendon
reflexes or myotomes arising from
a strictly neuroanatomically
plausible distribution is sought
(n = 6)
Chronic low back pain with or without lumbar related
leg pain (sciatica) (n = 150)
History of relevant neurological lesion or disease AND
pain in a neuroanatomical plausible distribution
Pain associated with negative sensory signs in the same
neuroanatomical plausible distribution
Diagnostic test (MRI) confirming a lesion or disease of
the somatosensory nervous system explaining the pain
Possible NP
(n = 23)
Probable NP
(n = 38)
Definite NP
(n = 63)
Unlikely to be NP
(n = 26)
No
No sensory changes,
but MRI scan confirms the
lesion, explaining the pain
(n = 9)
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statistical analysis was also carried out. Questionnaires 
with missing data were excluded from the analysis. The 
participants demographic and physiological characteris-
tics were presented descriptively using mean and ranges. 
Testing for normal distribution were carried out on con-
tinuous data using the Shapiro–Wilk test. If data was not 
normally distributed, the non-parametric equivalent were 
used. Statistical analysis was carried out with significance 
being considered at a 0.05 level. An independent sample 
t-test was used to compare differences in mean score for 
continuous variables (age, chronicity, lowest NRS, average 
NRS, highest NRS, current number of analgesic drugs con-
sumed, Fagerström score, STarT Back distress subscore, 
and total STarT Back score). Difference in mean were 
checked by sex (male, female), smoking status (smoker, 
non-smoker), and frequency of cigarettes smoked (10 or 
less, more than 20).
The One-Way ANOVA test will be used to compare the 
mean Fagerström scores, ranging from 0 to 10, between 
the four neuropathic pain grades. The chi-square test will 
be used to test for association between two categorical 
variables. This included smoking status (yes, no), sex (male, 
female), worst pain location (lower back, lower limb), most 
distal pain radiation (lower back, knee, upper calf, lower 
calf/ankle, foot).
The difference in the two proportion z-test was used to 
compare the percentage of patients whose worst pain was 
located in the lower limb between males and females, and 
between smokers of 10 cigarettes or less and smokers of 
more than 20 cigarettes. 
Multinomial logistic regression analysis was used to 
relate a categorical dependent variable (IASP “definite/
probable” grade) to all possible predictors if an initial sta-
tistical correlation was found. Odds ratios (OR) with 95% 
confidence interval (CI) will be computed. 
RESULTS
1. Sample description
Fig. 1 and 2 provide a flow diagram of the participants 
enrolled in this study. Tables 1-4 show the baseline de-
mographic and descriptive data of the subjects within the 
chronic pain group. Table 4 clearly shows a larger percent-
age of smokers (56.0%) than lifetime non-smokers (35.0%) 
who have an IASP “definite” neuropathic pain grade. Con-
versely, there is a more significant percentage (P = 0.026) 
of lifetime non-smokers (23.0%) than smokers (6.0%) who 
have an IASP “unlikely” neuropathic pain grade. There 
was a significant association between smoking status and 
occupation (P = 0.048), however occupation was not signif-
icantly associated with the IASP neuropathic pain grading 
(P = 0.095). The control group was adequately age (P = 0.874) 
and sex (P = 0.934) matched. However, there was a statisti-
cally significant difference (P = 0.009) in the number of 
current smokers between the chronic pain group (33.3%) 
and the control group (14.0%) (Appendix).
2. Comparison of current smokers and lifetime non-
smokers within the chronic pain group
There was a significant difference in the mean pain score (P 
= 0.025), mean Fagerström score (P < 0.001) and mean total 
Table 1. Mean Patient Characteristics Scores Grouped by Smoking Status 
Patient characteristic Smoker (n = 50) Non-smoker (n = 100) P value
Age (yr) 57.2 ± 11.9 61.6 ± 13.6 0.055
Lowest pain score (NRS) (range 0-10) 2.2 ± 2.2  2.1 ± 2.2  0.678
Average pain score (NRS) (range 0-10) 5.9 ± 2.3  4.9 ± 2.6  0.025
Highest pain score (NRS) (range 0-10) 8.8 ± 1.6  8.4 ± 1.6 0.178
Pain chronicity (yr) 4.5 ± 5.8  5.5 ± 8.1 0.415
Current number of analgesic drug classes consumed 1.2 ± 1.1  1.1 ± 1.0  0.528
Fagerström score (range 0-10) 4.2 ± 2.2  0.0 ± 0.0 < 0.001
STarT Back distress score (range 0-5) 2.7 ± 1.3  2.3 ± 1.5 0.068
STarT Back total score (range 0-9) 5.3 ± 1.9 4.4 ± 2.1 0.015
Values are presented as mean ± standard deviation.
NRS: numerical rating scale.
Table 2. Association Between Worst Pain Location and the Current 
Smoking Status 
Variable
Smoking status
Total
Yes No
Worst pain location
    Lower back 16 (32.0) 52 (52.0) 68 (45.3)
    Lower limb 34 (68.0) 48 (48.0) 82 (54.7)
Total 50 (100.0) 100 (100.0) 150 (100.0)
Values are presented as number (%). 
X2(1) = 5.380, P = 0.020.
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STarT Back score (P = 0.015) between current smokers and 
lifetime non-smokers. There were no significant differ-
ences between the two groups in the other variables (Table 
1). The difference between the two groups in the mean 
age (yr) nearly achieved statistical significance (P = 0.055). 
There was no statistically significant difference (P = 0.102) 
between male smokers (45.6%) and female smokers (54.4%) 
(Appendix - Sex). 
1) Worst pain location and radiation 
A significantly larger percentage of the current smokers 
(68.0%) reported the lower limb as their worst pain loca-
tion, compared to non-smokers (48.0%) (P = 0.020) (Table 
2). There was a significantly (P = 0.042) larger proportion 
of lifetime non-smokers (31.0%) which reported pain local-
ized to the low back, while a more significant percentage 
of current smokers (50.0%) reported pain radiation into the 
foot (Table 3).
2) Relationship between IASP neuropathic pain grade and 
patient characteristics
The multinomial logistic regression model (Appendix - 
Multinomial logistic model) which relates the IASP neu-
ropathic pain grade to eleven predictors, adjusted for age, 
sex, average pain intensity, and psychological distress, 
identifies four significant predictors, where the most distal 
pain radiation is the best predictor of neuropathic pain 
(P < 0.001), followed by the STarT Back score (P < 0.001), 
sex (P = 0.001), and worst pain location (P = 0.035). These 
four predictors (sex, worst pain location, most distal pain 
radiation, total STarT Back score) explain 67.7% of the total 
variation in the IASP neuropathic pain grades (Nagelkerke 
Pseudo R square value = 0.677).
3) Current smoking and sex 
More male smokers (61.5%) were graded with a “definite” 
neuropathic pain grade compared to females (50.0%). 
However, this difference is not significant (P = 0.728). The 
mean patient characteristic scores between male and fe-
male smokers were not significant (Appendix - Sex).
4) Dose-response effect
Fig. 3 shows that the mean Fagerström score increases 
significantly with a correspondingly higher IASP neuro-
pathic pain grade (P < 0.005). The mean Fagerström score 
increases from 0.42 ± 1.50 for subjects with an “unlikely” 
neuropathic pain grade to 2.17 ± 2.82 in subjects graded 
having a “definite” neuropathic pain grade (Appendix - 
Dose-response effect). The mean patient characteristic 
scores between heavy smokers (≥ 21 cigarettes daily) and 
light smokers (0-10 cigarettes daily) were compared (Table 
5). There was a statistically significant difference between 
the two groups in the mean Fagerström score (P < 0.001), 
STarT Back distress subscore (P = 0.001), the total STarT 
Back score (P < 0.001), and in the percentage of subjects 
classified as having “definite” neuropathic pain between 
light smokers (35.7%) and heavy smokers (81.3%) (P = 0.011).
3. Risk factors for the presence of chronic low back 
pain and radicular neuropathic pain
1) Sex 
The male sex was not significantly associated with having 
chronic low back pain, including lumbar related leg pain 
(sciatica) (P = 0.934; 95% CI, 0.537-1.965) or with having 
chronic radicular neuropathic pain (IASP “definite/prob-
able” grade) (P = 0.227; 95% CI, 0.769-3.022), rather than 
being pain-free (Appendix - Risk factors).
Table 3. Association Between Most Distal Pain Radiation in the Lower 
Limb and Smoking Status 
Variable
Smoking status
Total
Yes No
Most distal pain radiation
    Lower back 5 (10.0) 31 (31.0) 36 (24.0)
    Thigh and knee 6 (12.0) 16 (16.0) 22 (14.7)
    Upper calf 4 (8.0) 6 (6.0) 10 (6.7)
    Lower calf and ankle 10 (20.0) 14 (14.0) 24 (16.0)
    Foot 25 (50.0) 33 (33.0) 58 (38.7)
Total 50 (100.0) 100 (100.0) 150 (100.0)
Values are presented as number (%).
X2(4) = 9.930, P = 0.042.
Table 4. Association Between IASP Neuropathic Pain Grades and Smok-
ing Status 
Variable
Smoking status
Total
Yes No
IASP neuropathic pain grade
    Definite 28 (56.0) 35 (35.0) 63 (42.0)
    Probable 12 (24.0) 26 (26.0) 38 (25.3)
    Possible 7 (14.0) 16 (16.0) 23 (15.3)
    Unlikely 3 (6.0) 23 (23.0) 26 (17.3)
Total 50 (100.0) 100 (100.0) 150 (100.0)
Values are presented as number (%). 
X2(3) = 9.197, P = 0.026. 
IASP: International Association for the Study of Pain.
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2) Age 
An increase in age was not significantly associated with 
having chronic low back pain, including lumbar related 
leg pain (sciatica) (P = 0.873; 95% CI, 0.977-1.027) or with 
having chronic radicular neuropathic pain (IASP “definite/
probable” grade) (P = 0.824; 95% CI, 0.977-1.030), rather 
than being pain-free (Appendix - Risk factors).
3) Current smoker status 
Compared to a lifetime non-smoker, a current smoking 
status yielded an OR of 3.071 (P = 0.011; 95% CI, 1.289-
7.316) for the presence of chronic low back pain, including 
lumbar related leg pain (sciatica), rather than being pain-
free. The OR that a current smoker has chronic radicular 
neuropathic pain (IASP “definite/probable” grade) rather 
than being pain-free, is 4.028 times that of a lifetime non-
smoker (P = 0.002; 95% CI, 1.650-9.837) (Appendix - Risk 
factors).
4) Nicotine dependence - Fagerström score
Every 1 unit increase in the Fagerström score increases the 
odds that a patient has chronic low back pain, including 
lumbar related leg pain (sciatica) by 40.9% (P = 0.007; 95% 
CI, 1.096-1.812), rather than being pain-free. Every 1 unit 
increase in the Fagerström score increases the odds that 
a patient has chronic radicular neuropathic pain (IASP 
“definite/probable” grade) by 50.8% (P = 0.002; 95% CI, 
1.160-1.961), rather than being pain-free (Appendix - Risk 
factors).
DISCUSSION 
The results of this cross-sectional study support the hy-
Table 5. Dose-response Effect of Daily Cigarette Consumption
Patient characteristic 0-10 cigarettes daily (n = 14) ≥ 21 cigarettes daily (n = 16) P value
Fagerström score (range 0-10) 1.71 ± 1.14 6.25 ± 1.48 < 0.001
Age (yr) 55.0 ± 14.35 58.5 ± 9.48 0.432
Chronicity (yr) 3.15 ± 2.92 6.61 ± 8.44 0.156
Lowest pain score (NRS) (range 0-10) 2.6 ± 2.6 2.5 ± 2.3 0.938
Average pain score (NRS) (range 0-10) 6.3 ± 2.6 6.3 ± 2.6 0.984
Highest pain score (NRS) (range 0-10) 8.9 ± 1.8 9.1 ± 1.4 0.652
STarT Back distress subscore (range 0-5) 2.21 ± 0.89 3.56 ± 1.15 0.001
STarT Back total score (range 0-9) 4.14 ± 1.66 6.65 ± 1.36 < 0.001
Lower limb as worst pain location 9 (64.3) 12 (75.0) 0.522
IASP neuropathic pain grade 
    Unlikely 1 (7.1) 0 (0.0) 0.276
    Possible 2 (14.3) 1 (6.3) 0.465
    Probable 6 (42.9) 2 (12.5) 0.060
    Definite 5 (35.7) 13 (81.3) 0.011
Most distal pain radiation 
    Low back only 1 (7.1) 2 (12.5) 0.624
    Till knee level 2 (14.3) 0 (0.0) 0.119
    Upper calf 1 (7.1) 1 (6.3) 0.920
    Lower calf or ankle 1 (7.1) 4 (25.0) 0.190
    Foot 9 (64.3) 9 (56.3) 0.653
Values are presented as mean ± standard deviation or number (%).
NRS: numerical rating scale, IASP: International Association for the Study of Pain.
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Fig. 3. The 95% confidence intervals for the mean Fagerström score by 
International Association for the Study of Pain (IASP) neuropathic pain 
grade category.
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pothesis that a higher Fagerström score and a current 
smoking status, both independently increase the risk for 
chronic low back pain and radicular neuropathic pain. 
Current smokers have higher mean pain intensity and 
higher total STarT Back scores compared to lifetime non-
smokers. However, this study failed to identify sex differ-
ences in the outcomes. A recent study by Khan et al. [15] 
found that, compared to non-smokers, current smokers 
had a higher pain intensity while certain domains of the 
STarT Back tool (pain interference, physical functioning, 
depression, and anxiety; all P < 0.001) were also more sig-
nificantly prevalent in this population when assessed us-
ing a respective full length questionnaire. 
1. Smoking prevalence in subjects with chronic low 
back pain
The prevalence of tobacco smokers in the European Re-
gion population is 28% while in the US it stands at 17% 
[32]. In chronic pain sufferers the percentage of smokers is 
higher, ranging from 28.3%-82.2% [33-36]. Our study found 
a smoking prevalence of 33.3% amongst subjects with 
chronic pain, this being slightly higher than the European 
Region standard. In the control group (pain free) only 
14% were smokers. This reflects the association between 
chronic pain and smoking, especially patients suffering 
from chronic neuropathic pain, who are more prone to 
be dependent on nicotine and hence consume more ciga-
rettes daily. 
2. Nicotine addiction 
To the authors’ best knowledge, there is, as yet, no paper 
evaluating nicotine dependence in chronic low back pain 
subjects utilizing the IASP neuropathic pain grading sys-
tem, so direct comparison with other studies is limited. 
Probably the study by Çelik et al. [16] is the most similar 
to ours, since it used the DN4 and the Fagerström score. 
Their study concluded that patients with neuropathic pain 
(positive DN4 score) consumed more packets of cigarettes 
per year compared to those who obtained a negative DN4 
score (P < 0.05).
Similarly, we found that current smokers who had a 
higher Fagerström score (P = 0.005) or consumed a higher 
number of cigarettes (P = 0.011) had a higher chance of 
being diagnosed with chronic neuropathic pain. In Çelik 
et al. [16], each standard deviation increase in the Fager-
ström score (2.7) yielded an OR of 1.29 (95% CI, 1.14-1.46). 
However, our study obtained an OR of 1.409 (95% CI, 1.096-
1.812) for chronic low back pain and sciatica and an OR 
of 1.508 (95% CI, 1.160-1.961) for chronic radicular neu-
ropathic pain for every 1 unit increase in the Fagerström 
score. Therefore, our study portrays a much higher OR, 
primarily due to the way results are presented (standard 
deviation increase vs. 1 unit increase in Fagerström score) 
and possibly due to the differences in the populations be-
ing investigated. Çelik et al. [16] did not analyze their OR in 
comparison to a smoking-free control group, but their OR 
were compared to subjects having a negative score on the 
DN4. These participants could still be experiencing noci-
ceptive pain which is captured with the IASP neuropathic 
pain grading system, but not by the methodology adopted 
by Çelik et al. [16]. 
Other studies [37-39] examined nicotine dependence 
and low back pain. However their results could not be 
compared directly to ours since they used different meth-
ods to examine nicotine dependence, namely, the Diag-
nostic Interview Schedule (DIS-III-R) in Shaw et al. [38] 
and the World Health Organization’s Composite Interna-
tional Diagnostic Interview (WHO-CIDI) in Zvolensky et 
al. [39]. Shemory et al. [37] failed to mention which method 
was used to asses nicotine dependency. Furthermore, 
none of these studies examined the neuropathic pain 
component of low back pain, but rather two papers [38,39] 
looked explicitly at chronic low back pain, while Shemory 
et al. [37] did not mention if their paper was evaluating ei-
ther acute or chronic low back pain. These four papers [37-
40] concluded that nicotine dependence provided higher 
ORs (range, 1.95-4.49) compared to this study (1.508). 
However, the different diagnostic criteria for nicotine de-
pendence and the potentially diverse populations of sub-
jects with low back pain can significantly alter the ORs.
3. Smoking status 
Various systematic reviews [8-10,40-43] have explored the 
relationship between low back pain, sciatica, and smoking. 
However, these studies do not adhere to the same concept 
underlying sciatica and hence differ in their definitions 
of it. Furthermore, these studies do not mention if neuro-
pathic pain was assessed. A systematic review by Cook et 
al. [10] found “inconsistent operational definitions” under-
lying sciatica, raging from referred pain below the knee, or 
a definitive or non-definitive area in the lower limb, to a 
medical diagnosis during hospital admission. Such a spec-
trum of definitions will impact the inclusion and exclusion 
criteria of the respective studies making interpretation 
of results more difficult. A limitation of the studies men-
tioned above is that they evaluated smoking status only, 
and therefore, did not asses for nicotine dependency. This 
can have stronger implications within a biopsychosocial 
context. Furthermore, some of these reviews [10,40,42] did 
not asses the relationship between smoking and chronic 
sciatica, hence such discrepancies between these studies 
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and the current one must be considered.
A systematic review by Ferreira et al. [8] (Assessing the 
Methodological Quality of Systematic Reviews [AMSTAR] 
grade 6, n = 1,960), assessing twin subjects with chronic 
low back pain, was identified by an umbrella review [9]. 
The previous review found an OR of 3.0 (95% CI, 2.8-3.3), 
which is comparable to this study. However, this review 
did not differentiate between chronic and acute back pain, 
and it provided a pooled OR for the most persistent low 
back pain occurrence. The same umbrella review identi-
fied a systematic review by Cook et al. [10] (AMSTAR grade 
7, n = 7,701) looking for the risk factors underlying first-
time incidence sciatica, which was limited by the lack 
of diagnostic criteria underlying sciatica. Cook et al. [10] 
found an OR ranging from 1.5 (95% CI, 1.1-2.1) to 9.6 (95% 
CI, 1.7-53.0). Our OR for low back and lumbar related leg 
pain, in which the latter could be interpreted as sciatica, 
was 3.071 and, while for radicular neuropathic pain, which 
can also be interpreted as sciatica, was 4.028. Both of our 
ORs fit within the range of ORs provided [10], but our sys-
tematic approach in defining the neuropathic pain grades 
of sciatica could provide more reproducible and reliable 
results. 
A scoping review by Green et al. [43] identified two sys-
tematic reviews [40,41]. Shiri et al. [41] found that current 
smoking yields an OR of 1.79 (95% CI, 1.27-2.50; n = 31,811) 
for developing chronic low back pain, while Shiri et al. [40] 
conducted a systematic review which studied the associa-
tion of smoking with lumbar radicular pain. However, it 
did not conduct a meta-analysis of the selected papers, 
and hence it failed to provide an OR. 
A meta-analysis [42] examined the risk of smoking in 
regards to sciatica. Current smokers had an OR of 1.64 (95% 
CI, 1.24-2.16; n = 10,853) for lumbar radicular pain, and an 
OR of 1.35 (95% CI, 1.09-1.68; n = 110,374) for clinically veri-
fied sciatica. However, this review did not provide any in-
formation on what constituted “clinically verified sciatica” 
with only brief mentions of nerve root irritation. Yet these 
can vary in nature, with negative sensory and motor signs 
carrying a higher diagnostic value towards neuropathic 
pain [17].
In the current study, both smoking status and the Fag-
erström score were found to be significantly related to the 
IASP neuropathic pain grade when analyzed individu-
ally. However, in the logistic regression model, these two 
predictors were not found to be significant when analyzed 
collectively with other predictors. It is well known that a 
lone predictor could be rendered a very important contrib-
utor in explaining variations in the IASP neuropathic pain 
grade, but could be rendered unimportant in the presence 
of other predictors, for example worst pain location, distal 
pain radiation, and total STarT Back score. The suitability 
of a predictor in a fitted model often depends on what the 
other predictors are included with it. 
4. Sex 
Possibly due to the relatively small sample size, our study 
could not find a statistically significant association be-
tween sex and smoking status (P = 0.102) and a sex sub-
group analysis evaluating exclusively current smokers 
could not establish a significant difference across all the 
variables being studied. This is similar to most previous 
studies, yet one study [44] found that only males who were 
current smokers had a significant prevalence of lumbo-
sacral radicular pain. Likewise, in a 28-year longitudinal 
study [45] found that male smokers had a hazard ratio 
(HR) of 2.0 (95% CI, 1.1-3.6) for developing sciatica, while 
females had an HR of 1.8 (95% CI, 0.8-3.9).
5. Strengths and limitations of the study
The exclusion of former smokers is one of the strengths 
of this study, since it avoids the introduction of any con-
founding factors, for example, the length of time partici-
pants had stopped smoking and any on-and-off smoking 
periods. Furthermore, previous smoking can substantially 
outlast the smoking-free interval [10], thus possibly in-
fluencing the results of a study. Hence, a limitation of the 
current study is its cross-sectional nature and the small 
sample size. 
This study assessed nicotine dependency rather than 
just exclusively evaluating the smoking status and daily 
cigarette consumption. Exploration of this potentially 
treatment-modifiable construct could further unravel the 
complexity of the biopsychosocial model of chronic spinal 
pain. There was a high enrollment and completion rate, 
while the control group and the chronic pain group were 
sex- and age-matched, therefore the basic demographic 
differences should not affect the results.
Diagnosing neuropathic pain is essential, as it tends to 
lower the quality of life to a higher degree compared to 
nociceptive pain. A strength of the current study was the 
use of the IASP neuropathic pain grading system to grade 
the presence of neuropathic pain in chronic low back pain 
subjects with or without lumbar related leg pain (sciatica). 
Most of the papers cited [10,11,40,42,43] did not quantify 
the neuropathic pain component of sciatica, while neu-
ropathic pain questionnaires, such as DN4, yield variable 
sensitivities and specificities [18,19]. The use of the IASP 
neuropathic pain grading system is considered a strength 
of the current study since it offers a valid and reliable tool, 
making comparison of results between subjects and any 
future studies possible. 
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The population of the study was very specific: subjects 
with chronic low back and/or leg pain. This makes the 
participants more homogenous, but limits generalization 
to other back pain presentations e.g., acute or subacute 
and to other neuropathic pain conditions. This study did 
not assess how long current smokers have engaged in this 
activity, which might have been hindered by a significant 
element of recall bias. A large proportion of subjects (about 
75%) in both groups recounted a history of at least 15 years 
of smoking but f luctuated in the daily consumption of 
cigarettes. Despite the dose-response analysis carried out 
in this paper, the temporal aspects of daily cigarette con-
sumption could influence the symptomatology and possi-
bly affect the conclusion of this study. The study group was 
a consecutive sample of patients referred from the state 
acute hospital. Subjects who were not keen to engage in 
physiotherapy could have been missed by this study. This 
might have introduced selection bias. However, the study 
group is representative of the clinic caseload. 
This study concluded that a higher nicotine dependence, 
measured by the Fagerström score, increases the risk for 
chronic low back pain, sciatica and radicular neuropathic 
pain. Future research, possibly using longitudinal stud-
ies, could further investigate this association and possible 
causation. 
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Appendix
Control group matching 
Group
Sex
Total
Male Female
Chronic pain Count 64 86 150
Percentage 75.3 74.8 75.0
Pain free Count 21 29 50
Percentage 24.7 25.2 25.0
Total Count 85 115 200
Percentage 100.0 100.0 100.0
X2(1) = 0.007, P = 0.934.
Group Sample size Mean age
Standard 
deviation
Standard 
error
Chronic pain 150   60.13 13.179 1.076
Pain free   50 59.8 11.622 1.644
t(198) = 0.159, P = 0.874.
Group
Smoking status
Total
Yes No
Chronic pain Count 50 100 150
Percentage 87.7 69.9 75.0
Pain free Count 7 43 50
Percentage 12.3 30.1 25.0
Total Count 57 143 200
Percentage 100.0 100.0 100.0
X2(1) = 6.879, P = 0.009.
Occupation 
The association between occupation and smoking status
Occupation 
Smoking status
Total
Yes No
Housewife/man Count 8 30 38
Percentage 16.0 30.0 25.3
Light work Count 14 34 48
Percentage 28.0 34.0 32.0
Manual work Count 28 36 64
Percentage 56.0 36.0 42.7
Total Count 50 100 150
Percentage 100.0 100.0 100.0
X2(2) = 6.0789, P = 0.048.
Nicotine dependence and neuropathic back pain
Korean J Pain 2020;33(4):359-377www.epain.org
373
The association between occupation and IASP neuropathic pain grade
Occupation 
IASP neuropathic pain grade
Total
Unlikely Possible Probable Definite
Housewife/man Count 9 8 9 12 38
Percentage 34.6 34.8 23.7 19.0 25.3
Light work Count 8 11 12 17 48
Percentage 30.8 47.8 31.6 27.0 32.0
Manual work Count 9 4 17 34 64
Percentage 34.6 17.4 44.7 54.0 42.7
Total Count 26 23 38 63 150
Percentage 100.0 100.0 100.0 100.0 100.0
IASP: International Association for the Study of Pain.
X2(6) = 10.8, P = 0.095.
Sex 
The association between sex and smoking status
Sex
Smoking status
Total
Yes No
Male Count 26 38 64
Percentage 52.0 38.0 42.7
Female Count 24 62 86
Percentage 48.0 62.0 57.3
Total Count 50 100 150
Percentage 100.0 100.0 100.0
X2(1) = 2.671, P = 0.102.
IASP neuropathic pain grade in male and female current smokers 
IASP neuropathic pain 
grade
Sex (current smokers)
Total
Male Female
Definite Count 16 12 28
Percentage 61.5 50.0 56.0
Probable Count 5 7 12
Percentage 19.2 29.2 24.0
Possible Count 4 3 7
Percentage 15.4 12.5 14.0
Unlikely Count 1 2 3
Percentage 3.8 8.3 6.0
Total Count 26 24 50
Percentage 100.0 100.0 100.0
IASP: International Association for the Study of Pain.
X2(3) = 1.303, P = 0.728.
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Mean patient characteristics scores grouped by male and female smokers
Patient characteristic
Sex (current smokers)
P valueMale (n = 26) Female (n = 24)
Mean Standard deviation Mean Standard deviation
Fagerström score 4.62 2.43 3.83 1.93 0.212
Age (yr) 55.77 9.56 58.79 14.01 0.375
Chronicity (yr) 4.75 7.02 4.18 4.37 0.734
Current analgesic drug classes consumed 1.00 1.06 1.33 1.09 0.283
Lowest pain score (NRS) 1.96 2.11 2.54 2.30 0.357
Average pain score (NRS) 5.42 2.42 6.46 2.13 0.115
Highest pain score (NRS) 8.42 1.84 9.21 1.22 0.083
STarT Back distress subscore 2.69 1.35 2.75 1.22 0.087
STarT Back total score 5.31 2.22 5.29 1.63 0.971
NRS: numerical rating scale.
Patient characteristic
Sex (current smokers)
P valueMale (n = 26) Female (n = 24)
Frequency Percentage Frequency Percentage
Worst pain location 
    Low back 11 42.3 5 20.8 0.103
    Lower limb 15 57.7 19 79.2 0.103
Most distal pain radiation
    Low back 3 11.5 2 8.3 0.704
    Till knee level 5 19.2 1 4.2 0.101
    Upper calf 3 11.5 1 4.2 0.337
    Lower calf/ankle 5 19.2 5 20.8 0.889
    Foot 10 38.5 15 62.5 0.089
Multinomial logistic model
Likelihood ratio tests
Effect
Model fitting criteria Likelihood ratio tests
df P value
-2 Log Likelihood Chi-square
Average pain score (NRS) 223.946 1.174 3 0.759
Pain chronicity (yr) 224.633 1.861 3 0.602
Age (yr) 225.299 2.527 3 0.470
Fagerström score 223.632 0.860 3 0.835
STarT Back distress subscore 229.826 7.054 3 0.070
STarT Back total score 229.881 7.109 3 0.068
Current number of analgesic drug classes consumed 225.638 2.866 3 0.413
Sex 238.343 15.571 3 0.001
Cigarettes per day 225.156 2.384 9 0.984
Worst pain location 233.374 10.602 3 0.014
Most distal pain radiation 282.982 60.210 12 0.000
 NRS: numerical rating scale.
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Dose-response effect 
Mean Fagerström score grouped by IASP neuropathic pain grade category 
IASP neuropathic 
pain grade
Sample size
Mean 
Fagerström 
score
Standard 
deviation
P value
Definite 63 2.17 2.820 0.005
Probable 38 1.00 1.816
Possible 23 1.13 2.117
Unlikely 26 0.42 1.501
IASP: International Association for the Study of Pain.
The relationship between daily cigarette consumption and the total Fagerström score 
Cigarettes/
day
Total Fagerström score Grand 
total0 1 2 3 4 5 6 7 8
0-10 2 4 5 2 1 14
11-20 3 2 3 9 2 1 20
21-30 1 2 6 3 1 13
31 or more 1 2   3
Grand total 2 4 9 4 4 11 8 5 3 50
Risk factors for the presence of chronic low back pain and radicular neuropathic pain 
Sex 
Chronic low 
back pain
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 1.087 0.215 25.627 1 < 0.001
Male 0.027 0.331 0.007 1 0.934 1.028 0.537 1.965
Female 0 . . 0 . . . .
The reference category is: Control group.
CI: confidence interval.
IASP (definite/
probable)
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 0.504 0.235 4.590 1 0.032
Male 0.422 0.349 1.461 1 0.227 1.525 0.769 3.022
Female 0 . . 0 . . . .
The reference category is: Control group.
IASP: International Association for the Study of Pain, CI: confidence interval.
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Age
Chronic low 
back pain
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 0.976 0.782 1.559 1 0.212
Age 0.002 0.013 0.026 1 0.873 1.002 0.977 1.027
The reference category is: Control group.
CI: confidence interval.
IASP (definite/
probable)
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 0.521 0.835 0.389 1 0.533
Age 0.003 0.014 0.050 1 0.824 1.003 0.977 1.030
The reference category is: Control group.
IASP: International Association for the Study of Pain, CI: confidence interval.
Current smoker status 
Chronic low 
back pain
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 0.844 0.182 21.418 1 < 0.001
Smoker 1.122 0.443 6.421 1 0.011 3.071 1.289 7.316
Non-smoker 0 . . 0 . . . .
The reference category is: Control group.
CI: confidence interval.
IASP (definite/
probable)
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 0.350 0.199 3.084 1 0.079
Smoker 1.393 0.456 9.355 1 0.002 4.028 1.650 9.837
Non-smoker 0 . . 0 . . . .
The reference category is: Control group.
IASP: International Association for the Study of Pain, CI: confidence interval.
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Nicotine addiction - Fagerström score
Chronic low 
back pain
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 0.836 0.177 22.361 1 < 0.001
Fagerström score 0.343 0.128    7.168 1     0.007 1.409 1.096 1.812
The reference category is: Control group.
CI: confidence interval.
IASP (definite/
probable)
B Standard error Wald df P value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept 0.345 0.193 3.211 1 0.073
Fagerström score 0.411 0.134 9.400 1 0.002 1.508 1.160 1.961
The reference category is: Control group.
IASP: International Association for the Study of Pain, CI: confidence interval.
